| Clinical, prognostic, and therapeutic aspects of urachal carcinoma—a comprehensive review with meta-analysis of 1,010 cases T Szarvas, O Módos, C Niedworok, H Reis, A Szendröi, MA Szász, ... Urologic Oncology: Seminars and Original Investigations 34 (9), 388-398, 2016 | 186 | 2016 |
| Prognostic value of tissue and circulating levels of IMP3 in prostate cancer T Szarvas, S Tschirdewahn, C Niedworok, G Kramer, S Sevcenco, H Reis, ... International journal of cancer 135 (7), 1596-1604, 2014 | 176 | 2014 |
| The long noncoding RNA HOTAIR has tissue and cell type-dependent effects on HOX gene expression and phenotype of urothelial cancer cells J Heubach, J Monsior, R Deenen, G Niegisch, T Szarvas, C Niedworok, ... Molecular cancer 14, 1-17, 2015 | 122 | 2015 |
| Biomarkers in urachal cancer and adenocarcinomas in the bladder: a comprehensive review supplemented by own data H Reis, U Krafft, C Niedworok, O Módos, T Herold, M Behrendt, ... Disease markers 2018 (1), 7308168, 2018 | 67 | 2018 |
| Validation of circulating MMP-7 level as an independent prognostic marker of poor survival in urinary bladder cancer T Szarvas, T Jäger, M Becker, S Tschirdewahn, C Niedworok, I Kovalszky, ... Pathology & Oncology Research 17, 325-332, 2011 | 65 | 2011 |
| Inhibitory role of the small leucine-rich proteoglycan biglycan in bladder cancer C Niedworok, K Röck, I Kretschmer, T Freudenberger, N Nagy, T Szarvas, ... PloS one 8 (11), e80084, 2013 | 61 | 2013 |
| Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance O Módos, H Reis, C Niedworok, H Rübben, A Szendröi, J Tímár, K Baghy, ... Oncotarget 7 (26), 39293, 2016 | 56 | 2016 |
| The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder C Niedworok, I Kretschmer, K Röck, F Vom Dorp, T Szarvas, J Heß, ... PLoS One 8 (9), e75681, 2013 | 53 | 2013 |
| P athogenic and targetable genetic alterations in 70 urachal adenocarcinomas H Reis, KE van der Vos, C Niedworok, T Herold, O Módos, A Szendrői, ... International Journal of Cancer 143 (7), 1764-1773, 2018 | 52 | 2018 |
| Urachal carcinoma of the bladder: impact of clinical and immunohistochemical parameters on prognosis C Niedworok, M Panitz, T Szarvas, H Reis, AC Reis, A Szendröi, ... The Journal of Urology 195 (6), 1690-1696, 2016 | 49 | 2016 |
| Diagnostic and prognostic value of long noncoding RNAs as biomarkers in urothelial carcinoma J Droop, T Szarvas, WA Schulz, C Niedworok, G Niegisch, ... PLoS One 12 (4), e0176287, 2017 | 46 | 2017 |
| High insulin‐like growth factor mRNA‐binding protein 3 (IMP3) protein expression is associated with poor survival in muscle‐invasive bladder cancer T Szarvas, F Dorp, C Niedworok, A Melchior‐Becker, JW Fischer, ... BJU international 110 (6b), E308-E317, 2012 | 43 | 2012 |
| Soluble syndecan‐1 (SDC1) serum level as an independent pre‐operative predictor of cancer‐specific survival in prostate cancer T Szarvas, H Reis, F Vom Dorp, S Tschirdewahn, C Niedworok, P Nyirady, ... The Prostate 76 (11), 977-985, 2016 | 41 | 2016 |
| Prognostic effect of serum and tissue YKL-40 levels in bladder cancer S Tschirdewahn, H Reis, C Niedworok, P Nyirady, A Szendröi, ... Urologic Oncology: Seminars and Original Investigations 32 (5), 663-669, 2014 | 34 | 2014 |
| Timing and targeting of cell-based VEGF165 gene expression in ischemic tissue T Spanholtz, A Maichle, C Niedworok, BM Stoeckelhuber, S Krüger, ... Journal of Surgical Research 151 (1), 153-162, 2009 | 31 | 2009 |
| Truncated isoforms of lncRNA ANRIL are overexpressed in bladder cancer, but do not contribute to repression of INK4 tumor suppressors MJ Hoffmann, J Dehn, J Droop, G Niegisch, C Niedworok, T Szarvas, ... Non-coding RNA 1 (3), 266-284, 2015 | 29 | 2015 |
| Renal cell carcinoma and tumour thrombus in the inferior vena cava: clinical outcome of 98 consecutive patients and the prognostic value of preoperative parameters C Niedworok, B Dörrenhaus, F Vom Dorp, JA Piotrowski, S Tschirdewahn, ... World journal of urology 33, 1541-1552, 2015 | 24 | 2015 |
| Serum chromogranin A as a complementary marker for the prediction of prostate cancer-specific survival C Niedworok, S Tschirdewahn, H Reis, N Lehmann, M Szuecs, P Nyirády, ... Pathology & Oncology Research 23, 643-650, 2017 | 23 | 2017 |
| Validation of the diagnostic and prognostic relevance of serum MMP-7 levels in renal cell cancer by using a novel automated fluorescent immunoassay method C Niedworok, F Vom Dorp, S Tschirdewahn, H Rübben, H Reis, M Szucs, ... International Urology and Nephrology 48, 355-361, 2016 | 23 | 2016 |
| Circulating and tissue expression levels of YKL-40 in renal cell cancer F Vom Dorp, S Tschirdewahn, C Niedworok, H Reis, H Krause, ... The journal of urology 195 (4), 1120-1125, 2016 | 21 | 2016 |
